Changeflow GovPing Pharma & Drug Safety DNA Editing Using Single-Stranded DNA - EP33035...
Routine Rule Added Final

DNA Editing Using Single-Stranded DNA - EP3303585A1 Patent Grant

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

The European Patent Office published patent grant EP3303585A1 for DNA editing using single-stranded DNA. The patent names Board of Regents of the University of Nebraska and Tokai University Educational System as applicants. The invention covers biotechnology methods for DNA editing with applications in genetic research and development.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The European Patent Office published patent application EP3303585A1 for DNA editing using single-stranded DNA. The patent application covers methods and compositions related to genetic engineering applications. The designated states include major European Patent Convention member states including Germany, France, United Kingdom, Italy, Spain, Netherlands, Belgium, Switzerland, Austria, and others.\n\nBiotechnology companies, research institutions, and genetic engineering firms operating in Europe should review this patent to understand existing intellectual property claims in the DNA editing space. Parties conducting research or developing products involving single-stranded DNA editing techniques may need to consider licensing requirements or design-around strategies to avoid potential infringement.

Archived snapshot

Apr 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

DNA EDITING USING SINGLE-STRANDED DNA

Publication EP3303585A1 Kind: A1 Apr 08, 2026

Applicants

Board of Regents of the
University of Nebraska, Tokai University Educational System

Inventors

GURUMURTHY, Channabasavaiah, B., MIURA, Hiromi, OHTSUKA, Masato

IPC Classifications

C12N 15/10 20060101AFI20180926BHEP C12N 15/63 20060101ALI20180926BHEP C12N 15/82 20060101ALI20180926BHEP C12N 15/87 20060101ALI20180926BHEP C12N 5/10 20060101ALI20180926BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3303585A1

Who this affects

Applies to
Educational institutions Manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Patent grant Biotech research Genetic engineering
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!